ClinicalTrials.gg
Sign In

Febrile Neutropenia clinical trials

The registry lists 147 studies for Febrile Neutropenia across more than 10 countries. 36 are recruiting or about to start. 86 of them are mainly about Febrile Neutropenia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Febrile Neutropenia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
69
Status unknown
21
Recruiting
19
Not yet recruiting
17
Terminated
11
Withdrawn
6

Phase

Phase 4
28
Phase 2
23
Phase 3
18
Phase 1
6

Where

China
20
United States
18
France
16
Spain
8
Korea, Republic of
7
Italy
5

Who runs them

Pfizer (4) · Jiangsu HengRui Medicine Co., Ltd. (4) · Assistance Publique - Hôpitaux de Paris (3) · The University of Hong Kong (3) · University Hospital, Lille (2) · Insel Gruppe AG, University Hospital Bern (2) · Brigham and Women's Hospital (2) · Poitiers University Hospital (2)

What is being tested here

Drugs under test in Febrile Neutropenia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ceftazidime204
Amoxicillin212
Clavulanic Acid212
Ciprofloxacin113
Pegfilgrastim113
Granulocyte Colony-Stimulating Factor112
Pegylated granulocyte colony-stimulating factor101
Fosfomycin111
Cefepime004
Vancomycin014

Drug classes tested here Beta-lactamase inhibitors 3 open

Coming up

4phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 19 Febrile Neutropenia studies recruiting now, 11 (58%) set no upper age limit and 8 (42%) stop at 75 or younger. 4 (21%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
104 (21%)4 (21%)
1819 (100%)19 (100%)
3015 (79%)15 (79%)
4015 (79%)15 (79%)
5015 (79%)15 (79%)
6515 (79%)15 (79%)
7514 (74%)14 (74%)
8511 (58%)11 (58%)

Across all 147 studies, recruiting or not: 36% stop at 75 or younger and 25% at 65; 25% take children; 7% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Febrile Neutropenia studies take

Of 21 observational studies under Febrile Neutropenia, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase26 mo16–50 · 16 studies——
Observational25 mo13–60 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Results posted1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 147. Browse all 147 → or search them.